Rachel Swart

1.4k total citations
11 papers, 671 citations indexed

About

Rachel Swart is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rachel Swart has authored 11 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Pathology and Forensic Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rachel Swart's work include Viral-associated cancers and disorders (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Advanced Breast Cancer Therapies (2 papers). Rachel Swart is often cited by papers focused on Viral-associated cancers and disorders (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Advanced Breast Cancer Therapies (2 papers). Rachel Swart collaborates with scholars based in United States, France and Netherlands. Rachel Swart's co-authors include Richard Longnecker, Ingrid K. Ruf, Jeffery T. Sample, Sara Fruehling, Elisabeth Kremmer, Laurence Cooke, Daruka Mahadevan, Kimiko Della Croce, Harinder S. Garewal and Lee Wisner and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Rachel Swart

11 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel Swart United States 9 353 202 194 191 101 11 671
Dimitri Salameire France 13 266 0.8× 131 0.6× 82 0.4× 102 0.5× 262 2.6× 24 550
Georg Aue United States 16 199 0.6× 350 1.7× 434 2.2× 240 1.3× 63 0.6× 52 1.0k
T Takizawa Japan 11 352 1.0× 76 0.4× 239 1.2× 169 0.9× 122 1.2× 16 702
Masaya Taniwaki Japan 13 294 0.8× 61 0.3× 103 0.5× 364 1.9× 210 2.1× 49 761
Derek Yau China 8 152 0.4× 107 0.5× 48 0.2× 204 1.1× 204 2.0× 12 541
Sophie Gazzo France 16 247 0.7× 121 0.6× 453 2.3× 266 1.4× 43 0.4× 32 856
M. Durante United States 10 184 0.5× 138 0.7× 57 0.3× 242 1.3× 88 0.9× 23 601
Tsui‐Lien Mao Taiwan 14 321 0.9× 84 0.4× 146 0.8× 500 2.6× 161 1.6× 24 1.0k
Tawfiq Henni France 12 194 0.5× 217 1.1× 326 1.7× 103 0.5× 22 0.2× 26 686
María José Brito Portugal 16 226 0.6× 55 0.3× 179 0.9× 238 1.2× 222 2.2× 45 790

Countries citing papers authored by Rachel Swart

Since Specialization
Citations

This map shows the geographic impact of Rachel Swart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Swart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Swart more than expected).

Fields of papers citing papers by Rachel Swart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Swart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Swart. The network helps show where Rachel Swart may publish in the future.

Co-authorship network of co-authors of Rachel Swart

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Swart. A scholar is included among the top collaborators of Rachel Swart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Swart. Rachel Swart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
3.
Mahadevan, Daruka, Noah Theiss, Laurence Cooke, et al.. (2014). Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST). Oncotarget. 6(4). 1954–1966. 25 indexed citations
4.
Bowden, Chris, Paul J. Miller, Rachel Swart, et al.. (2014). Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies. Cancer Chemotherapy and Pharmacology. 73(3). 467–473. 35 indexed citations
5.
Wildiers, Hans, Anthony Gonçalvès, Margaret Kemeny, et al.. (2012). Phase Ib study of open-label AMG 386 plus paclitaxel (P) and trastuzumab (T) or capecitabine (C) and lapatinib (L) in patients (pts) with HER2+ locally recurrent or metastatic breast cancer (MBC).. Journal of Clinical Oncology. 30(15_suppl). 529–529. 2 indexed citations
6.
Mahadevan, Daruka, Laurence Cooke, Christopher Riley, et al.. (2007). A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors. Oncogene. 26(27). 3909–3919. 224 indexed citations
7.
Merchant, Mark, Rachel Swart, Rebecca B. Katzman, et al.. (2001). The Effects of the Epstein-Barr Virus Latent Membrane Protein 2a on B Cell Function. International Reviews of Immunology. 20(6). 805–835. 36 indexed citations
8.
Swart, Rachel, Ingrid K. Ruf, Jeffery T. Sample, & Richard Longnecker. (2000). Latent Membrane Protein 2A-Mediated Effects on the Phosphatidylinositol 3-Kinase/Akt Pathway. Journal of Virology. 74(22). 10838–10845. 129 indexed citations
9.
Swart, Rachel, Sara Fruehling, & Richard Longnecker. (1999). Tyrosines 60, 64, and 101 of Epstein–Barr Virus LMP2A Are Not Essential for Blocking B Cell Signal Transduction. Virology. 263(2). 485–495. 15 indexed citations
10.
Yoon, Joon Won, Liu C, Jian Yang, et al.. (1998). GLI Activates Transcription through a Herpes Simplex Viral Protein 16-Like Activation Domain. Journal of Biological Chemistry. 273(6). 3496–3501. 71 indexed citations
11.
Fruehling, Sara, et al.. (1998). Tyrosine 112 of Latent Membrane Protein 2A Is Essential for Protein Tyrosine Kinase Loading and Regulation of Epstein-Barr Virus Latency. Journal of Virology. 72(10). 7796–7806. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitri Salameire Breakdown of academic impact, for papers by Georg Aue Breakdown of academic impact, for papers by T Takizawa Breakdown of academic impact, for papers by Masaya Taniwaki Breakdown of academic impact, for papers by Derek Yau Breakdown of academic impact, for papers by Sophie Gazzo Breakdown of academic impact, for papers by M. Durante Breakdown of academic impact, for papers by Tsui‐Lien Mao Breakdown of academic impact, for papers by Tawfiq Henni Breakdown of academic impact, for papers by María José Brito
Rankless by CCL
2026